At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 61 enrolled
Drug / intervention
Oleogel-S10 ointment +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Open, Blindly Evaluated, Prospective, Controlled, Randomized, Multicenter Phase III Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Standard of Care in Accelerating the Healing of Grade 2a Partial-Thickness Burn Wounds
In Brief
A Phase 3 clinical trial evaluating Oleogel-S10 ointment and Octenilin® wound gel for Burns. Completed, enrolled 61 participants across 9 sites in 4 countries.
Detailed Summary
The main goal of this phase III clinical trial is to show safety and efficacy of Oleogel-S10 in the acceleration of wound healing of grade 2a burn wounds.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBurns
CountriesGermany, Sweden, Switzerland, United Kingdom
Collaborators--
Timeline
Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2012
First PostedAug 2012
Primary CompletionJul 2013
Study CompletionJul 2014
TodayJul 2026
First PostedAug 6, 2012
Enrollment StartAug 1, 2012
Primary CompletionJul 1, 2013
Study CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 13.9 years ago
Interventions
Oleogel-S10 ointmentdrug
Intraindividual comparison: One randomly assigned wound half is treated with Oleogel-S10 ointment and fatty gauze wound dressing
Octenilin® wound geldevice
Intraindividual comparison: The other wound half is treated with Octenilin® wound gel and fatty gauze wound dressing